Clinical Trials

New Search
Title   A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Fulvestrant in Subjects With HR+/HER2- Advanced or Metastatic Breast Cancer
Disease/Condition   Breast Cancer,Skin Disorders,Medical and Hematologic Oncology,Neoplasms
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Sun Young Oh, MD
Contact Name   Priscilla Vazquez
Contact Email   pvazquez@montefiore.org
IRB/Protocol Number   16-06-378-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   HR+/HER2- Breast Cancer